Yier Pharmaceutical Technology (Weifang) Co., Ltd.

Medical technology research and development, promotion and consulting services; sales: chemical raw materials, traditional Chinese medicines, granules, capsules, solid beverages, food, food additives, veterinary drugs, feed additives, chemical products (excluding hazardous chemicals and easy-to-make products) toxic chemicals), chemical equipment, instrumentation, machinery and equipment; engage in the import and export business of goods and technology within the scope permitted by the state (items that require approval according to law can only be carried out after approval by relevant departments)
Business Type Manufacturer
Location ChinaShandongWeifang
Year Established 2018-12-27
Total Employees 0
Total Annual Revenue -
Main Products 2,2-dihydroxymethylbutyric acid, indazole, 2,6-dimethylpyrazine, 2-ethylanthraquinone, 3,4,5-trimethoxybenzaldehyde, decabromodiphenylethane, 8-hydroxyquinoline, 8-hydroxyquinoline, tetrahydrofuran, DOP, ethanolamine, diisocyanate, glabridin, decabromodiphenylethane, decabromodiphenyl ether, pyrazine, indazole, imidazole, quinazoline, Quinazoline, alpha arbutin, quinoline, tetrahydropyrrole, tetrahydropyrrole, calcium bromide, tetrahydrofuran, tetrahydrothiophen-3-one, p-fluoronitrobenzene, magnesium ascorbyl phosphate, camphorsulfonic acid, additives , nitro, phosphate ester, vitamins, food additives, anthraquinone, hyaluronic acid, isophthalic acid, food additives
Main Market -